Recent Analyst Forecasts and Stock Ratings
Entrada Therapeutics Inc FAQ's
Entrada Therapeutics Inc has been rated by research analysts at Guggenheim, Oppenheimer, Roth Capital, H.C. Wainwright in the past 90 days.
Entrada Therapeutics Inc has been rated by research analysts at Guggenheim, Oppenheimer, Roth Capital, H.C. Wainwright in the past 90 days.